Search results
Buy Epigral; target of Rs 2000: Emkay Global Financial
CNBC Awaaz· 5 days agoEmkay Global Financial is bullish on Epigral has recommended buy rating on the stock with a target...
Nykaa expects 23% revenue growth, GMV increase in Q1FY25, stock gains
CNBC Awaaz· 1 day agoFSN E-Commerce Ventures, which owns beauty and fashion platform Nykaa has projected a robust revenue...
Shark Awards 2024: marketing sets a new gold standard - ET BrandEquity
The Economic Times· 3 days agoWinners of the Shark Awards 2024 were announced on July 5. Nine winners were awarded under the 'Special Awards' category.
Diensten Tech makes powerful debut, lists with 140% premium on NSE SME
CNBC Awaaz· 6 days agoThe profit per lot is Rs 1,68,000.
Bansal Wire IPO subscribed 31x on final day as QIBs rush in
CNBC Awaaz· 4 days agoAhead of the public issue, Bansal Wire raised Rs 223.5 crore from anchor investors, including SBI...
Budget 2024: Income Tax Standard Deduction For Salaried Employees May Rise To Rs 1 Lakh - News18
News18· 3 days agoUnion Budget 2024: The finance ministry is reportedly considering raising the standard deduction...
Get ready for higher brokerage charges under Sebi's new diktat
CNBC Awaaz· 6 days agoThe capital market diktat of levying uniform exchange fee on all broking firms irrespective of the...
Trade setup for Tuesday: Top 15 things to know before the opening bell
CNBC Awaaz· 14 hours agoAs long as this level holds, the index is likely to hit 24,500 after ongoing consolidation, while...
Subscribe- Long Term Emcure Pharmaceuticals Ltd; Anand Rathi
CNBC Awaaz· 7 days agoAnand Rathi, has come out with its report on Emcure Pharmaceuticals Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.
Kingdon Capital, involved in Adani-Hidenburg saga, has only one other India connection
CNBC Awaaz· 4 days agoiShares is a collection of exchange-traded funds (ETFs) managed by BlackRock.